LOREGIAN, ARIANNA

LOREGIAN, ARIANNA  

Dipartimento di Medicina Molecolare - DMM  

Mostra records
Risultati 1 - 20 di 123 (tempo di esecuzione: 0.05 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Antiviral strategies against influenza virus: an update on approved and innovative therapeutic approaches 2025 Bonomini A.Mercorelli B.Loregian A. CELLULAR AND MOLECULAR LIFE SCIENCES - -
Design, synthesis, and biological evaluation of first-in-class indomethacin-based PROTACs degrading SARS-CoV-2 main protease and with broad-spectrum antiviral activity 2024 Desantis, JennyBazzacco, AlessandroTuci, SaraMercorelli, BeatriceLoregian, Arianna + EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY - -
Elaborate Structural Modifications Yielding Novel Boron-Containing N-Substituted Oseltamivir Derivatives as Potent Neuraminidase Inhibitors with Significantly Improved Broad-Spectrum Antiresistance Profiles 2024 Bonomini, AnnaBertagnin, ChiaraLoregian, Arianna + JOURNAL OF MEDICINAL CHEMISTRY - -
Exploring a New Generation of Pyrimidine and Pyridine Derivatives as Anti-Influenza Agents Targeting the Polymerase PA–PB1 Subunits Interaction 2024 Bertagnin C.Bonomini A.Loregian A. + PHARMACEUTICS - -
Human neural progenitor cell models to study the antiviral effects and neuroprotective potential of approved and investigational human cytomegalovirus inhibitors 2024 Trevisan M.Apolloni L.Mercorelli B.Loregian A. + ANTIVIRAL RESEARCH - -
Optimization of potent, broad-spectrum, and specific anti-influenza compounds targeting RNA polymerase PA-PB1 heterodimerization 2024 Bonomini A.Bertagnin C.Mercorelli B.Loregian A. + EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY - -
Switching the three-component Biginelli-like reaction conditions for the regioselective synthesis of new 2-amino[1,2,4]triazolo[1,5-a]pyrimidines 2024 Bonomini, AnnaBertagnin, ChiaraLoregian, Arianna + ORGANIC & BIOMOLECULAR CHEMISTRY - -
Synergistic activity of an RNA polymerase PA-PB1 interaction inhibitor with oseltamivir against human and avian influenza viruses in cell culture and in ovo 2024 Bonomini A.Mercorelli B.Loregian A. + ANTIVIRAL RESEARCH - -
A novel N-heterocycles substituted oseltamivir derivatives as potent inhibitors of influenza virus neuraminidase: discovery, synthesis and biological evaluation 2023 Bertagnin C.Bonomini A.Loregian A. + JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY - -
A small molecule targeting the interaction between human papillomavirus E7 oncoprotein and cellular phosphatase PTPN14 exerts antitumoral activity in cervical cancer cells 2023 Bertagnin C.Celegato M.Sturlese M.Mercorelli B.Moro S.Loregian A. + CANCER LETTERS - -
Design, Synthesis, and Biological Evaluation of Trisubstituted Piperazine Derivatives as Noncovalent Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease Inhibitors with Improved Antiviral Activity and Favorable Druggability 2023 Mercorelli B.Loregian A. + JOURNAL OF MEDICINAL CHEMISTRY - -
Discovery of N-substituted oseltamivir derivatives as novel neuraminidase inhibitors with improved drug resistance profiles and favorable drug-like properties 2023 Bonomini A.Lucca C.Bertagnin C.Loregian A. + EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY - -
IN VITRO ANTIVIRAL ACTIVITY OF EPIGALLOCATECHIN GALLATE AGAINST RABIES VIRUS 2023 D. PasqualA. LoregianC. Salata - - Abstract Book
Small-Molecule Inhibitor of Flaviviral NS3-NS5 Interaction with Broad-Spectrum Activity and Efficacy In Vivo 2023 Celegato M.Sturlese M.Trevisan M.Favaro A.Moro S.Loregian A.Mercorelli B. + MBIO - -
Contemporary medicinal chemistry strategies for the discovery and optimization of influenza inhibitors targeting vRNP constituent proteins 2022 Loregian A. + ACTA PHARMACEUTICA SINICA B - -
Discovery of Novel Boron-Containing N-Substituted Oseltamivir Derivatives as Anti-Influenza A Virus Agents for Overcoming N1-H274Y Oseltamivir-Resistant 2022 Bertagnin, ChiaraBonomini, AnnaLoregian, Arianna + MOLECULES - -
Discovery of novel SARS-CoV-2 inhibitors targeting the main protease Mpro by virtual screenings and hit optimization 2022 Mercorelli, BeatriceDesantis, JennyCelegato, MartaBazzacco, AlessandroLoregian, Arianna + ANTIVIRAL RESEARCH - -
HPV-induced cancers: preclinical therapeutic advancements 2022 Messa L.Loregian A. EXPERT OPINION ON INVESTIGATIONAL DRUGS - -
Iterative Optimization and Structure-Activity Relationship Studies of Oseltamivir Amino Derivatives as Potent and Selective Neuraminidase Inhibitors via Targeting 150-Cavity 2022 Bonomini, AnnaBertagnin, ChiaraLoregian, Arianna + JOURNAL OF MEDICINAL CHEMISTRY - -
Targeted disruption of e6/p53 binding exerts broad activity and synergism with paclitaxel and topotecan against hpv-transformed cancer cells 2022 Celegato M.Messa L.Bertagnin C.Mercorelli B.Loregian A. CANCERS - -